Dmitry Karshtedt is mentioned in Law360 regarding the impact of a recent Federal Circuit decision clamping down on broad antibody patent claims.
"Biologics Face Tougher Patent Scrutiny After Amgen Ruling"
February 18, 2021
Dmitry Karshtedt is mentioned in Law360 regarding the impact of a recent Federal Circuit decision clamping down on broad antibody patent claims.